2023 Was a tricky yr to the biopharma market, with a number of providers downsizing and restructuring their workforces to remain afloat. There are signs of Restoration, as mergers and acquisitions picked up through the pharmaceutical and everyday living sciences market in the latter A part of 2023 and also https://sites.google.com/view/bio-sites/blog